Cardinal Health (CAH – Research Report) received a Buy rating and price target from Evercore ISI analyst Elizabeth Anderson CFA today. The ...

Fintel reports that on January 7, 2025, Evercore ISI Group upgraded their outlook for Cardinal Health (NYSE:CAH) from In-Line ...

The Dublin healthcare giant reported $226.8 billion in sales for FY24 that ended June 30, the ninth consecutive year of ...

Cardinal Health Inc. CAH is well-poised for growth, given its long-term supply agreements, diversified product portfolio and strong quarterly earnings. However, the possibility of losing a major ...

sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Learn more about whether Cardinal Health, Inc. or Fresenius Medical Care AG is a better investment based on AAII's A+ ...

Learn more about whether Cardinal Health, Inc. or DaVita Inc. is a better investment based on AAII's A+ Investor grades, ...

Cardinal Health will also acquire the Advanced Diabetes Supply Group (ADSG), one of the country's leading diabetic medical supplies providers, for approximately $1.1 billion in cash. ADSG will ...

The latest trading day saw Cardinal Health (CAH) settling at $119.63, representing a +0.28% change from its previous close.

In the most recent trading session, Cardinal Health (CAH) closed at $117.92, indicating a -1.02% shift from the previous trading day.

Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care ...